Hematological and Biochemical Evaluation of Acute and Sub-acute Oral Toxicity of Azanza garckeana Hydroethanolic Fruit Extract in Male Wistar Rats
Emerging Frontiers in Translational Biomedicine and Health Sciences · 19.12.2025 · 1 (2) · 72-96
DOI: 10.66779/m2zk7j89 ↗Kurz gefasst
Fachartikel in der Zeitschrift Emerging Frontiers in Translational Biomedicine and Health Sciences, online erschienen am 19.12.2025. Verfasst von Akinyele Olubiyi Akinsola und 3 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Background
Azanza garckeana is a widely used African medicinal plant, particularly for reproductive health and various ailments. Despite its ethnomedicinal applications and pharmacological evidence, comprehensive data on the safety of its hydroethanolic fruit extract remain limited. This study evaluated the acute and sub-acute (15 and 30 days) oral toxicity of hydroethanolic fruit extract of Azanza garckeana (AZG) in male Wistar rats, focusing on hematological, biochemical, and oxidative stress markers.
Methods
Acute toxicity was assessed using Lorke's method. For sub-acute studies, rats received daily oral doses of hydroethanolic fruit extract of Azanza garckeana (200, 400, or 800 mg/kg) or distilled water for 15 or 30 days (n = 5/group). Body weight, food/fluid intake, hematology, serum biochemistry, and tissue oxidative stress markers were evaluated. Data were analyzed by one-way ANOVA followed by Tukey's post-hoc test (p5000 mg/kg, indicating low acute toxicity. At 15 days, minor changes included decreased platelet distribution width (all doses) and mean platelet volume (800 mg/kg), increased HDL-cholesterol (800 mg/kg), reduced blood urea nitrogen (all doses), and enhanced antioxidant markers (e.g., glutathione and glutathione peroxidase) in liver, kidney, and heart, with no evidence of organ damage. After 30 days, changes included improved lipid profile (decreased total/LDL-cholesterol, increased HDL), mild hematological modulations (e.g., decreased red cell distribution width), reduced food intake (400–800 mg/kg) without weight loss, and sustained catalase elevation in heart (800 mg/kg). No hepatotoxicity or nephrotoxicity was observed.
Conclusion
AZG exhibited no significant toxicity at doses up to 800 mg/kg/day for 30 days. The no-observed-adverse-effect level (NOAEL) under the present experimental conditions is 800mg/kg/day. These findings support its relative safety, with observed changes suggesting no adverse effects but potential hypolipidemic, antioxidant, and hematological modulations.
Zitieren
APA
Akinsola, A. O., Ojezele, M. O., Eduviere, A. T., & Akpovwre, C. O. (2025). Hematological and Biochemical Evaluation of Acute and Sub-acute Oral Toxicity of Azanza garckeana Hydroethanolic Fruit Extract in Male Wistar Rats. Emerging Frontiers in Translational Biomedicine and Health Sciences, 1(2), 72-96. https://doi.org/10.66779/m2zk7j89
Vancouver
Akinsola AO, Ojezele MO, Eduviere AT, Akpovwre CO. Hematological and Biochemical Evaluation of Acute and Sub-acute Oral Toxicity of Azanza garckeana Hydroethanolic Fruit Extract in Male Wistar Rats. Emerging Frontiers in Translational Biomedicine and Health Sciences. 2025;1(2):72-96. doi:10.66779/m2zk7j89
BibTeX
@article{Akinsola2025,
author = {Akinsola, Akinyele Olubiyi and Ojezele, Matthew Obaineh and Eduviere, Anthony Taghogho and Akpovwre, Celestine Ogheneruro},
title = {Hematological and Biochemical Evaluation of Acute and Sub-acute Oral Toxicity of Azanza garckeana Hydroethanolic Fruit Extract in Male Wistar Rats},
journal = {Emerging Frontiers in Translational Biomedicine and Health Sciences},
year = {2025},
volume = {1},
number = {2},
pages = {72--96},
doi = {10.66779/m2zk7j89}
}
EUVIMED